TR201916902A2 - Manyeti̇k levi̇tasyon düzeneği̇ i̇çi̇nde merceksi̇z holografi̇k mi̇kroskobi̇ görüntüleme tekni̇ği̇ni̇ kullanilarak protei̇n tespi̇ti̇ - Google Patents

Manyeti̇k levi̇tasyon düzeneği̇ i̇çi̇nde merceksi̇z holografi̇k mi̇kroskobi̇ görüntüleme tekni̇ği̇ni̇ kullanilarak protei̇n tespi̇ti̇ Download PDF

Info

Publication number
TR201916902A2
TR201916902A2 TR2019/16902A TR201916902A TR201916902A2 TR 201916902 A2 TR201916902 A2 TR 201916902A2 TR 2019/16902 A TR2019/16902 A TR 2019/16902A TR 201916902 A TR201916902 A TR 201916902A TR 201916902 A2 TR201916902 A2 TR 201916902A2
Authority
TR
Turkey
Prior art keywords
magnetic levitation
imaging technique
protein detection
levitation device
microscopy imaging
Prior art date
Application number
TR2019/16902A
Other languages
English (en)
Inventor
Yaman Sena
Deli̇koyun Kerem
Cumhur Teki̇n Hüseyi̇n
Original Assignee
Izmir Yueksek Teknoloji Enstituesue
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Izmir Yueksek Teknoloji Enstituesue filed Critical Izmir Yueksek Teknoloji Enstituesue
Priority to TR2019/16902A priority Critical patent/TR201916902A2/tr
Priority to PCT/TR2020/051002 priority patent/WO2021086293A2/en
Publication of TR201916902A2 publication Critical patent/TR201916902A2/tr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/41—Refractivity; Phase-affecting properties, e.g. optical path length
    • G01N21/45—Refractivity; Phase-affecting properties, e.g. optical path length using interferometric methods; using Schlieren methods
    • G01N21/453—Holographic interferometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/47—Scattering, i.e. diffuse reflection
    • G01N21/4788—Diffraction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/01—Arrangements or apparatus for facilitating the optical investigation
    • G01N21/03—Cuvette constructions
    • G01N2021/0346—Capillary cells; Microcells

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

Buluş, manyetik levitasyon platformuna entegre edilen merceksiz holografik mikroskop görüntüleme tekniği ile biyomolekül tespit edilmesi ile ilgilidir.
TR2019/16902A 2019-11-01 2019-11-01 Manyeti̇k levi̇tasyon düzeneği̇ i̇çi̇nde merceksi̇z holografi̇k mi̇kroskobi̇ görüntüleme tekni̇ği̇ni̇ kullanilarak protei̇n tespi̇ti̇ TR201916902A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2019/16902A TR201916902A2 (tr) 2019-11-01 2019-11-01 Manyeti̇k levi̇tasyon düzeneği̇ i̇çi̇nde merceksi̇z holografi̇k mi̇kroskobi̇ görüntüleme tekni̇ği̇ni̇ kullanilarak protei̇n tespi̇ti̇
PCT/TR2020/051002 WO2021086293A2 (en) 2019-11-01 2020-10-27 Protein detection using lensless holographic microscopy imaging technique in a magnetic levitation setup

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2019/16902A TR201916902A2 (tr) 2019-11-01 2019-11-01 Manyeti̇k levi̇tasyon düzeneği̇ i̇çi̇nde merceksi̇z holografi̇k mi̇kroskobi̇ görüntüleme tekni̇ği̇ni̇ kullanilarak protei̇n tespi̇ti̇

Publications (1)

Publication Number Publication Date
TR201916902A2 true TR201916902A2 (tr) 2021-05-21

Family

ID=75716199

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/16902A TR201916902A2 (tr) 2019-11-01 2019-11-01 Manyeti̇k levi̇tasyon düzeneği̇ i̇çi̇nde merceksi̇z holografi̇k mi̇kroskobi̇ görüntüleme tekni̇ği̇ni̇ kullanilarak protei̇n tespi̇ti̇

Country Status (2)

Country Link
TR (1) TR201916902A2 (tr)
WO (1) WO2021086293A2 (tr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015095395A1 (en) * 2013-12-17 2015-06-25 The General Hospital Corporation Microfluidic devices for isolating particles
CA2940650C (en) * 2014-02-26 2022-10-04 Brigham And Women's Hospital, Inc. System and method for cell levitation and monitoring

Also Published As

Publication number Publication date
WO2021086293A2 (en) 2021-05-06
WO2021086293A3 (en) 2021-06-17

Similar Documents

Publication Publication Date Title
CL2018003520A1 (es) Anticuerpos anti-b7-h3 y conjugados de anticuerpo y fármaco.
ES2500066T3 (es) Anticuerpos frente a ferroportina y métodos de uso
MX2016004579A (es) Proteinas de union del miembro 1 de la familia de transmembrana 4 l-seis (tm4sf1) y metodos de uso de las mismas.
BR112016014022A2 (pt) anticorpos anti-cd3, ácido nucleico isolado, vetor, célula hospedeira, método de produção do anticorpo anti-cd3, imunoconjugado, composição, uso do anticorpo anti-cd3, métodos de tratamento, métodos de intensificação da função imune e kit
MX2019003168A (es) Anticuerpos contra proteina alfa reguladora de se?al y metodos de uso.
CL2019000082A1 (es) Anticuerpos específicos para la tau hiperfosforilada y sus métodos de uso.
GT201700162A (es) Anticuerpos anti-cd3, anticuerpos anti-cd123 y anticuerpos biespecíficos que se unen específicamente a cd3 y/o cd123
CL2020000977A1 (es) Conjugados de fármaco-anticuerpo activable anti-cd71 y métodos de uso de estos.
DOP2015000243A (es) Proteínas de unión anti-lag-3
CR20240116A (es) RECEPTORES QUIMÉRICOS DE FLT3 Y MÉTODOS DE USO DE LOS MISMOS (Divisional 2018-518)
CL2017000278A1 (es) Moléculas biespecíficas de unión a antígeno activadoras de células t
EA201690299A1 (ru) СТАБИЛИЗАЦИЯ Fc-СОДЕРЖАЩИХ ПОЛИПЕПТИДОВ
MX2017011281A (es) Conjugados de amatoxina y anticuerpos.
MX384006B (es) Moleculas de union tri-especificas que se unen especificamente a varios antigenos de cancer y metodos de uso de los mismos.
CL2015002756A1 (es) Moléculas fc biespecíficas
MX2015017331A (es) Anticuerpos anti fc similar a receptor 5 (fcrh5).
BR112018075653A2 (pt) anticorpos anti-b7-h3 e conjugados anticorpo fármaco
CO6700829A2 (es) Moduladores novedosos y métodos de uso
CL2017002756A1 (es) Adhesivos acrílicos en emulsión
MX2015012825A (es) Anticuerpos monoclonales del dominio de union de lipido del núcleo del virus de la hepatitis c vhc.
MX381364B (es) Agentes activos en la superficie a base de policarbonato alifatico.
MX2016006551A (es) Preparacion de anticuerpos de cultivos de celula de ovario de hamster chino para conjugacion.
MX2019001853A (es) Separacion de fluido hidrocarbonado-agua.
EP3805390A4 (en) NAV1.7 MONOCLONAL ANTIBODY
MX2018013484A (es) Nuevos anticuerpos anti-tnfrsf21 y modos de uso.